Verano Holdings Corp. (VRNOF)
(Delayed Data from OTC)
$3.62 USD
-0.28 (-7.18%)
Updated Aug 2, 2024 03:59 PM ET
4-Sell of 5 4
B Value B Growth B Momentum A VGM
Brokerage Reports
Verano Holdings Corp. [VRNOF]
Reports for Purchase
Showing records 21 - 40 ( 145 total )
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Capital Remains Tight but Will Flow with Federal Reform Changes
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Cash Flow Key and Rescheduling Look
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Pressure on DEA to Reschedule After HHS Findings
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
2024 Cannabis Industry Outlook: Resetting and Anticipating Regulatory Catalysts
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: State Led Growth Story to Continue in 2024
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Yearly ReHash: Biggest Developments in Cannabis in 2023
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: New York Set to Expand Adult-use in 2024
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Green Wednesday - Cannabis Industry''s Black Friday
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
Company: Verano Holdings Corp.
Industry: Medical - Products
3Q23 Margin Gains Improve Bottom Line Higher CF Generation, Reit Buy
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Q323 Results Reaffirm Quality, Cashflow, and Growth Optionality. Catalyst Opportunities Materializing.
Provider: Echelon Welath Partners
Analyst: SEMPLE A
Company: Verano Holdings Corp.
Industry: Medical - Products
Consumer - Weekly ReHash: 3Q23 Earnings Week I
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Weekly ReHash: Declining Prices Drives Volume + Illicit Conversion
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Verano Holdings Corp.
Industry: Medical - Products
Cannabis Industry Update: 3Q23 Preview
Provider: Roth Capital Partners, Inc.
Analyst: Research Department